These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22892115)

  • 21. Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehyde.
    Bowman RK; Brown AD; Cobb JH; Eaddy JF; Hatcher MA; Leivers MR; Miller JF; Mitchell MB; Patterson DE; Toczko MA; Xie S
    J Org Chem; 2013 Dec; 78(23):11680-90. PubMed ID: 24171666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 1-((2R,4aR,6R,7R,7aR)-2-Isopropoxy-2-oxidodihydro-4H,6H-spiro[furo[3,2-d][1,3,2]dioxaphosphinine-7,2'-oxetan]-6-yl)pyrimidine-2,4(1H,3H)-dione (JNJ-54257099), a 3'-5'-Cyclic Phosphate Ester Prodrug of 2'-Deoxy-2'-Spirooxetane Uridine Triphosphate Useful for HCV Inhibition.
    Jonckers TH; Tahri A; Vijgen L; Berke JM; Lachau-Durand S; Stoops B; Snoeys J; Leclercq L; Tambuyzer L; Lin TI; Simmen K; Raboisson P
    J Med Chem; 2016 Jun; 59(12):5790-8. PubMed ID: 27181575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
    Hecker SJ; Reddy KR; van Poelje PD; Sun Z; Huang W; Varkhedkar V; Reddy MV; Fujitaki JM; Olsen DB; Koeplinger KA; Boyer SH; Linemeyer DL; MacCoss M; Erion MD
    J Med Chem; 2007 Aug; 50(16):3891-6. PubMed ID: 17636948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide prodrugs for HCV therapy.
    Sofia MJ
    Antivir Chem Chemother; 2011 Aug; 22(1):23-49. PubMed ID: 21860070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates.
    Shi J; Zhou L; Zhang H; McBrayer TR; Detorio MA; Johns M; Bassit L; Powdrill MH; Whitaker T; Coats SJ; Götte M; Schinazi RF
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7094-8. PubMed ID: 22014549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
    Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
    J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
    Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphoramidate and phosphate prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine: synthesis, anti-HIV activity and stability studies.
    Liang Y; Narayanasamy J; Schinazi RF; Chu CK
    Bioorg Med Chem; 2006 Apr; 14(7):2178-89. PubMed ID: 16314108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 2'-deoxy-2'-fluoro-2'-C-methyl uridine cyclopentyl carbocyclic analog and its phosphoramidate prodrug as inhibitors of HCV NS5B polymerase.
    Liu J; Du J; Wang P; Nagarathnam D; Espiritu CL; Bao H; Murakami E; Furman PA; Sofia MJ
    Nucleosides Nucleotides Nucleic Acids; 2012 Apr; 31(4):277-85. PubMed ID: 22444190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-HCV activity of β-d-2'-deoxy-2'-α-chloro-2'-β-fluoro and β-d-2'-deoxy-2'-α-bromo-2'-β-fluoro nucleosides and their phosphoramidate prodrugs.
    Ovadia R; Khalil A; Li H; De Schutter C; Mengshetti S; Zhou S; Bassit L; Coats SJ; Amblard F; Schinazi RF
    Bioorg Med Chem; 2019 Feb; 27(4):664-676. PubMed ID: 30655167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of 2'-deoxy-2'-fluoro-2'-C-methyl spiro cyclopentyl carbocyclic uridine analog as potential inhibitors of HCV NS5B polymerase.
    Singh US; Chu CK
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):52-68. PubMed ID: 32310031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.
    Furman PA; Murakami E; Niu C; Lam AM; Espiritu C; Bansal S; Bao H; Tolstykh T; Micolochick Steuer H; Keilman M; Zennou V; Bourne N; Veselenak RL; Chang W; Ross BS; Du J; Otto MJ; Sofia MJ
    Antiviral Res; 2011 Aug; 91(2):120-32. PubMed ID: 21600932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication.
    Pinho P; Kalayanov G; Westerlind H; Rosenquist Å; Wähling H; Sund C; Almeida M; Ayesa S; Tejbrant J; Targett-Adams P; Eneroth A; Lindqvist A
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3468-3471. PubMed ID: 28622881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.
    Tyndall EM; Draffan AG; Frey B; Pool B; Halim R; Jahangiri S; Bond S; Wirth V; Luttick A; Tilmanis D; Thomas J; Porter K; Tucker SP
    Bioorg Med Chem Lett; 2015 Feb; 25(4):869-73. PubMed ID: 25592710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
    Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
    Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.
    Erion MD; Reddy KR; Boyer SH; Matelich MC; Gomez-Galeno J; Lemus RH; Ugarkar BG; Colby TJ; Schanzer J; Van Poelje PD
    J Am Chem Soc; 2004 Apr; 126(16):5154-63. PubMed ID: 15099098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
    Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
    Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
    Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
    J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
    Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
    Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.
    Bourdin C; McGuigan C; Brancale A; Chamberlain S; Vernachio J; Hutchins J; Gorovits E; Kolykhalov A; Muhammad J; Patti J; Henson G; Bleiman B; Bryant KD; Ganguly B; Hunley D; Obikhod A; Walters CR; Wang J; Ramamurty CV; Battina SK; Srivinas Rao C
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2260-4. PubMed ID: 23453067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.